ACCESSIBILITY

24/7

Headlines

21:39

Full list of Israeli high-tech layoffs in 2026

21:36

Remitly cuts 110 jobs in Israel and closes R&D hub three years after $80 million Rewire acquisition

16:41

Rigas: "Energean needs more gas to compete, and to prevent a monopoly"

16:31

“When you raise walls around data, employees go around them”

Buzz

Most popular

Daily

Weekly

Israeli defense firms target Asia as Singapore Airshow opens amid regional arms race

Chinese fund: “The Chinese government has imposed a ban on any new investment in Israel”

Cyera employees to sell tens of millions in shares at $9 billion valuation

Medtronic to acquire Israeli AI cardiology firm CathWorks for $585 million, deal could reach $1 billion

Israeli startup raises $6.2 million to turn social media video into intelligence

More news

Pharmaceuticals

10 stories about Pharmaceuticals

Lonza to Open Research and Development Center in Israel

10.10.17|Lilach Baumer

The company is looking to boost the research and development projects of its pharma and biotech division

Drug Conduction Company Prepares for Nasdaq IPO

08.10.17|Golan Hazani

Clinical stage PolyPid develops technology for the predetermined, controlled and localized release of drugs at a targeted site

Teva’s Stock Drops After Approval of Copaxone Competitors

08.10.17|Lilach Baumer

A day after Mylan announced FDA approval for its generic versions of Copaxone, drug companies Synthon and Alvogen announce European approval for their 40 mg/ml generic versions of Teva's blockbuster drug

Pharma Companies Arcturus Therapeutics and Alcobra to Merge

28.09.17|Lilach Baumer

The merged entity will develop treatments for infectious diseases, cystic fibrosis, and rare liver diseases

Automated Medical Diagnosis Startup Raises $30 Million

19.09.17|Omer Kabir

Israel-based MeMed develops an automated blood testing device that can distinguish between bacterial and viral infections. The company previously raised funds from the U.S. Department of Defense

Teva Sells Remaining Women's Health Assets

18.09.17|Lilach Baumer

After selling its Paragard business for $1.1 billion last week, Teva's remaining Women's Health business will be split between CVC Capital Partners and Foundation Consumer Healthcare in a $1.38 billion cash deal

Teva Negotiating Sale of Remaining Women's Health Assets, Report Says

14.09.17|Lilach Baumer

CVC Capital Partners is nearing a $800 million deal for Teva's remaining Women's Health business, Bloomberg reported Thursday

IPO Hopeful Entera Bio Moves to Better Position

13.09.17|Dror Reich

Clinical-stage company Entera Bio develops pioneering technology for orphan disease hypoparathyroidism

The Ten Challenges Facing Teva's New CEO

12.09.17|Sophie Shulman

Kåre Schultz is the right man for the job, but he's facing multiple problems, from a changing market to a problematic board

Teva Appoints Lundbeck's Schultz as CEO

11.09.17|Dror Reich and Micky Grunfeld

The company’s announcement brings an end to a seven month search for a CEO to lead the troubled generic drugmaker. Updated